THERESA DURBIN: Open Payments
NPI 1639120967 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 39 payments from 18 companies in 2025. Trend: 2023 $94 · 2024 $307 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 5 | $135 |
| Calliditas Therapeutics US Inc. | 5 | $121 |
| Novartis Pharmaceuticals Corporation | 5 | $77 |
| Amgen Inc. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Novo Nordisk Inc | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| SCPHARMACEUTICALS INC. | 2 | $38 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $31 |
| Sandoz Inc. | 2 | $29 |
Products named: TARPEYO, ACTHAR, Fabhalta, TAVNEOS, JYNARQUE, JARDIANCE, FUROSCIX, TERLIVAZ.
Industry payments across IL — which companies pay providers there.
